Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Breakthrough for canine heart disease
Many dogs may benefit from study findings

A major international study has, for the first time, revealed a clear survival benefit associated with the administration of Pimobendan in the pre-clinical phase of canine heart disease.

Researchers administered the drug to around 1000 Doberman pinschers with pre-clinical dilated cardiomyopathy (DCM), and found that it gave a significant increase in overall survival time for those dogs, delaying the onset of heart failure or sudden death.

The study, which was carried out between 2006 and 2011 by veterinary cardiologists from ten centres in the UK, USA and Canada, has been published in the Journal of Veterinary Internal Medicine.

DCM is the most common cause of heart failure in large breed dogs, with 25-50 per cent of Dobermans developing DCM during their lifetimes.

Professor Adrian Boswood from the Royal Veterinary College (RVC), who took part in the study, said: “This high-quality and groundbreaking research is the first veterinary cardiology study to demonstrate the clear benefit of administering a drug to patients with DCM in the pre-clinical phase.
 
“It is exciting to be able to provide practitioners with a new treatment for dogs that are diagnosed with DCM, and owners with the opportunity to spend more time with their dog before they develop clinical signs and heart failure. We also hope that our findings will have wider benefits for all dogs diagnosed with DCM in the early stages of the disease."

Pet owners should contact their veterinary surgeon for advice on the best treatments for their pets.

Become a member or log in to add this story to your CPD history

FIVP publishes CMA Compliance Checklist

News Story 1
 FIVP has published a CMA Compliance Checklist to support independent practices with the Market Investigation Order.

The document includes deadlines for small and large businesses, with tick boxes for each of the tasks. The organisation also invites practices to contact them for support with requirements.

Rita Dingwall, FIVP chair, said: FIVP appreciates that navigating the new CMA requirements can feel daunting. We hope this checklist will make things a little easier, helping independent practices work through what is required with confidence. 

Click here for more...
News Shorts
APHA launches free virtual work experience programme

The Animal and Plant Health Agency (APHA), in collaboration with Springpod, has launched a free virtual work experience programme, giving young people across the UK the chance to explore careers dedicated to protecting animal and plant health.

The on-demand programme offers a unique insight into career opportunities within APHA, showcasing how students can contribute to tackling some of the UK's most critical biosecurity and environmental challenges.

Designed for students aged 13 and over, the course includes more than 10 hours of engaging content featuring real-life industry insights, scenario-based challenges, and practical guidance on applying for jobs. To register for the course, visit the APHA website.